共 50 条
- [31] Population Pharmacokinetic Analysis of Abiraterone in Chemotherapy-Naïve and Docetaxel-Treated Patients with Metastatic Castration-Resistant Prostate Cancer Clinical Pharmacokinetics, 2014, 53 : 1149 - 1160
- [33] Real-world first-line systemic therapy patterns in metastatic castration-resistant prostate cancer BJUI COMPASS, 2022, 3 (03): : 205 - 213
- [37] Economic Outcomes in Patients with Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate Plus Prednisone Advances in Therapy, 2020, 37 : 2083 - 2097
- [39] Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches RADIATION ONCOLOGY, 2018, 13
- [40] Metastatic castration-resistant prostate cancer therapy: the quest for the perfect molecule European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 883 - 884